UK

Corrigendum

Information

Published

External Reference: 2024-590900

FTS Reference: 2024-024409

Corrigendum

[NoticeCorrigendum]

[NoticeCorrigendumSub]

[Supplies]

[Section1]: [CaCe]

I.1)

[NameAddressContact]

Nottingham Trent University (NTU)
GB 277399933
50 Shakespeare Street
Nottingham
NG1 4FQ
UK
[Contactpoint]: Mark Lucas
[AddressPhone]: +44 1158488747
[AddressEmail]: mark.lucas@ntu.ac.uk
[Nutscode]:  UKF14 -  Nottingham
[Internets]:
[UrlGeneral]: https://www.ntu.ac.uk/
[UrlBuyerprofile]: https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

[Section2]: [Object]

II.1)

[QuantityScopeContract]

II.1.1)

[TitleContract]

Clinical Trial Manufacturing and Distribution Services
[Fileref]:  NTU/24/2615T/ML
II.1.2)

[CpvMain]

33600000  - 
II.1.3)

[TypeContract]

[Supplies]
II.1.4)

[DescrShort]

Nottingham Trent University requires Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.

[Section6]: [InfoComplement]

VI.6)

[IcarOriginalRef]

[NumberOj]: 2024/S 000-024231

[Section7]: [Changes]

VII.1)

[IcarCorrectAdd]

VII.1.2)

[IcarTextCorrected]

[SectionNo]:  1.5
[IcarTextCorrPlace]:  Section IV: Procedure
[IcarInstead]:  
[IcarRead]:  
Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.
VII.2)

[IcarOtherInfo]

Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.